AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT00644930 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: invasive ventilation
Description: Standard therapy group (invasive ventilation). Patients in need of endotracheal intubation were mechanically ventilated with Amadeus (Hamilton, Via Nova, Switzerland) and Esprit (Respironics, PA, USA) ventilators in the assist-control or synchronized intermittent mandatory ventilation (SIMV) mode.
Study NCT00307021 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049
Description: 3-dose intramuscular injection, 2 different formulations
Study NCT00307021 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: GSK Biologicals' candidate Plasmodium falciparum malaria vaccine 257049
Description: 3-dose intramuscular injection, 2 different formulations
Study NCT01178528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ivabradine
Description: 7.5 mg bd
Study NCT01178528 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Drug:Carvedilol and Drug:Ivabradine
Description: up to 12.5/5 mg bd
Study NCT01178528 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Carvedilol
Description: 25 mg bd
Study NCT01243437 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ciprofloxacin
Description: * For adults and children aged > 15 years: 500 mg orally every 12 hours for 10 days or until the patient has been fever-free for 24 hours, whichever is longer;~* For children aged 8-15 years: 15 mg/kg (maximum 500 mg per dose) orally every 12 hours for 10 days or until the patient has been fever-free for 24 hours, whichever is longer.
Study NCT01243437 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: doxyxcycline
Description: * For adults and children weighing 45 kg or more: 200 mg orally one time as an initial loading dose, followed by 100 mg orally every 12 hours for 10 days or until the patient has been fever-free for 24 hours, whichever is longer;~* For children weighing less than 45 kg: 4.4 mg/kg orally one time as an initial loading dose, followed by 2.2 mg/kg orally every 12 hours for 10 days or until the patient has been fever-free for 24 hours, whichever is longer.
Study NCT04204473 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: TY-9591(10mg,40mg) qd. po
Description: Increased dose cohorts from low dose to MTD(20mg Cohort1, 40mg Cohort2, 80mg Cohort3,120mg Cohort4, 160mg Cohort5, 200mg Cohort6)
Study NCT01591343 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Depigoid® (500 DPP/ml)
Description: Depigoid® D. pteronyssinus or Depigoid® 50% D. pteronyssinus / 50% D. farinae (500 DPP/ml).~Dose:~Week 0: 0.2 ml followed by 0.3 ml after 30 min Week 4, 8, 12, and 16: 0.5 ml Mode of administration: subcutaneous injection
Study NCT03190915 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bone Marrow Aspiration and Biopsy
Description: Undergo bone marrow aspiration or biopsy
Study NCT03190915 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Trametinib
Description: Given PO
Study NCT04150263 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Intraocular lens (IOL) ab externo scleral suture fixation
Description: traditional IOL scleral suture fixation
Study NCT04150263 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: Modified IOL ab externo scleral suture fixation
Description: Modified IOL scleral suture fixation
Study NCT02987452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: aerobic exercise
Description: Aerobic exercise (EA): activity on a treadmill lasting 45 minutes with intensity of 50-60% of maximum heart rate (HR) obtained from ergometer test
Study NCT02987452 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: aerobic exercise
Description: Aerobic exercise (EA): activity on a treadmill lasting 45 minutes with intensity of 50-60% of maximum heart rate (HR) obtained from ergometer test
Study NCT02987452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: resistance exercise
Description: resistance exercise (RE): 4 series of 12 repetitions of resistance exercises at moderate intensity (until moderate fatigue), for 45 minutes
Study NCT02987452 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: resistance exercise
Description: resistance exercise (RE): 4 series of 12 repetitions of resistance exercises at moderate intensity (until moderate fatigue), for 45 minutes
Study NCT01282307 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Guided Self-Determination GSD
Description: The method GSD consists of 21 worksheets designed to guide patient and mental health professionals through autonomy-supportive problem solving. The worksheets are filled in by the patient before and between conversations with their community nurse over 10 sessions, approximately 1 hour a session.
Study NCT01862471 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Neuromuscular Electrical Stimulation
Description: Frequency of 36Hz, a balanced biphasic waveform with a pulse width of 350μs, a ramp up time of 500ms, a contraction time of 1s and a ramp down time of 500ms.
Study NCT01862471 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Intermittent Pneumatic Compression
Description: Programmed to deliver compression every 20 seconds at a pressure of 130mmHg for a 1 second duration over a period of 5 minutes.
Study NCT01372072 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: non-invasive ventilation heated humidification (Fisher-Paykel MR810 and MR850 humidifiers)
Description: Heated humidification (Fisher-Paykel MR810 and MR850 humidifiers)
Study NCT02151981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chemotherapy
Description: Randomization to either Osimertinib or platinum-based doublet-chemotherapy on Day 1 of every 21d cycle in a 2:1 (Osimertinib:platinum-based doublet-chemotherapy) ratio
Study NCT02151981 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Chemotherapy
Description: Randomization to either Osimertinib or platinum-based doublet-chemotherapy on Day 1 of every 21d cycle in a 2:1 (Osimertinib:platinum-based doublet-chemotherapy) ratio
Study NCT02151981 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cross-over to Osimertinib
Description: Once subjects on the platinum-based doublet chemotherapy arm are determined to have objective radiological progression according to RECIST 1.1 by the investigator and confirmed by independent central imaging review, they will be given the opportunity to begin treatment with Osimertinib 80mg, once daily. These subjects may continue treatment with Osimertinib even after disease progression, as long as they are continuing to show clinical benefit, as judged by the investigator.~Subjects who stop platinum-based doublet chemotherapy for reasons other than objective disease progression according to RECIST 1.1 will not be eligible to cross-over to Osimertinib.
Study NCT02826434 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PVX-410
Description: This is a Vaccine that will be injected intramuscularly as a mixture with an adjuvant.
Study NCT02826434 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Durvalumab
Description: This is an intravenous infusion of a monoclonal antibody.
Study NCT02826434 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hiltonol
Description: This is an intramuscular injection of an adjuvant to enhance the immune response to vaccine.
Study NCT02978911 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: preoperative cerebral MRI and operative findings
Study NCT01948050 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: non-invasive transcranial direct current stimulation (tDCS)
Study NCT03294057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Tele-coaching programs
Description: Tele-coaching program conducted 12 times (one time for one week), and more than 20 minutes each by a trained nurse. Coaching content specifically, 1) evaluation, 2) facing and accepting the health crisis, 3) setting up new goals, 4) making decisions and plans, and 5) practice.
Study NCT03294057 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ICT programs
Description: ICT programs that include health information learning by disease and self-management based on Smart Management Strategy for Health (SMASH)
Study NCT03294057 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: A book about chronic disease
Description: A Take-home book about chronic disease are provided for self-education
Study NCT01823406 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: hyperglycemic clamp (elevated blood sugar to 300) for 4 hours
Study NCT00297349 — intervention group
Intervention type: DRUG
Intervention: Topiramate
Description: Individualization of the treatment should begin from 25 mg for 1 week.
Study NCT00979459 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1006 DFC
Description: Each dry filled capsule contains 20 mg MK-1006
Study NCT00979459 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: MK-1006 FCT
Description: Each film coated tablet contains 40 mg of MK-1006
Study NCT04239222 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Revo-M
Description: Investigational energy storage and return prosthetic foot with using novel elastic elements.
Study NCT01595451 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Acupuncture
Description: A licensed acupuncturist will perform acupuncture for six, 30 minute treatment sessions.
Study NCT01595451 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Acupuncture
Description: A licensed acupuncturist will perform acupuncture for six, 30 minute treatment sessions.
Study NCT02131922 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Intensive Treatment
Description: Intensive Surgical Treatment of Periodontitis
Study NCT02131922 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Dental Hygienization Treatment
Study NCT04239222 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Taleo
Description: Commercially available carbon-fiber energy storage and return foot used as comparative foot for transfemoral amputee subjects
Study NCT04239222 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Proflex XC
Description: Commercially available carbon-fiber energy storage and return foot used as comparative foot for transtibial amputee subjects
Study NCT01790178 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ultrasound
Description: The ultrasound guided group will have an ultrasound to identify the optimal site for biopsy and guide the procedure for safety purposes.
Study NCT02987452 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: combined exercise
Description: combined exercise (CE): EA (25 minutes) + ER (20 minutes), with an interval of 2 minutes between sessions totalizing 45 minutes
Study NCT02131922 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Chlorhexidine (Intensive Treatment)
Description: Chlorhexidine (PerioKIN) (0.2%) implantation in dental pockets
Study NCT03543904 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Pre-operative physiotherapy education
Description: Pre-operative education regarding post-operative physiotherapy intervention in children with abdominal surgery which includes,~1. Deep breathing exercises~2. Pursed lip breathing exercises~3. Diaphragmatic breathing exercises~4. Leg ROM (active hip and knee flexion, extension and abduction exercises)~5. Ankle toe movements exercises
Study NCT03543904 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Post-operative physiotherapy intervention
Description: Post-operative physiotherapy intervention which includes,~1. Deep breathing exercises~2. Pursed lip breathing exercises~3. Diaphragmatic breathing exercises~4. Leg ROM (active hip and knee flexion, extension and abduction exercises)~5. Ankle toe movements exercises
Study NCT02987452 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: combined exercise
Description: combined exercise (CE): EA (25 minutes) + ER (20 minutes), with an interval of 2 minutes between sessions totalizing 45 minutes
Study NCT01790256 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cereve Sleep System at 30 degrees C
Study NCT01790256 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Cereve Sleep System at 14-16 degrees C
Study NCT02099357 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Creatine
Description: Daily supplementation with 3g of monohydrate creatine during 8 weeks
Study NCT02099357 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Study NCT02099357 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Vitamin D
Description: Vitamin D supplementation with 25000 IU each two weeks during eight weeks
Study NCT01548482 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT01548482 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT01548482 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temsirolimus
Description: Given IV
Study NCT01548482 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Trebananib
Description: Given IV
Study NCT00989794 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GelrinC
Description: Applied once during surgery
Study NCT01010386 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Atmospheric oxygen tension
Description: Couples will have their gametes and embryos placed in the currently widely used atmospheric (20%) oxygen atmosphere
Study NCT01010386 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Physiologic oxygen tension
Description: Couples will have their gametes and embryos placed in a physiologic (5%) oxygen atmosphere
Study NCT01203150 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Exercise
Description: CRT will occur 3 times per week for 26 weeks. Each training session will last approximately 40-45 minutes and employ resistance training (weight lifting) and high-speed, low intensity endurance activities (arm cranking) with interposed periods of incomplete recovery (i.e., heart rate not falling to baseline).
Study NCT01203150 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Exercise
Description: CRT will occur 3 times per week for 26 weeks. Each training session will last approximately 40-45 minutes and employ resistance training (weight lifting) and high-speed, low intensity endurance activities (arm cranking) with interposed periods of incomplete recovery (i.e., heart rate not falling to baseline).
Study NCT04205305 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: conventional blood pressure control (labetalol, nicardipine)
Description: After successful recanalization, appropriate antihypertension medication is administered to control systolic blood pressure \<180 mmHg.
Study NCT04205305 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: intensive blood pressure control (labetalol, nicardipine)
Description: After successful recanalization, appropriate antihypertension medication is administered to control systolic blood pressure \<140 mmHg.
Study NCT00562276 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Immediate IUD insertion
Description: Insertion of either Paraguard or Mirena IUD within minutes of completing suction aspiration procedure between 5 and 12 weeks gestation
Study NCT00426855 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bendamustine
Description: starting with 60 mg/m\^ 2, IV, dose escalation, weekly d1,8,15 q5w
Study NCT00426855 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bortezomib
Description: weekly 1.5mg/m\^2, IV, d1,8,15,22 q5w
Study NCT03807869 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: combined glaucoma surgery
Description: phacoemulsification of cataract and I-stent by-pass implantation
Study NCT03272074 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Egg and egg white
Description: Participants will consume either one large eggs or equivalent amount of egg white (3/4 cups) for 12 weeks. Participants will maintain their regular diet and physical activities.
Study NCT03272074 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Egg and egg white
Description: Participants will consume either one large eggs or equivalent amount of egg white (3/4 cups) for 12 weeks. Participants will maintain their regular diet and physical activities.
Study NCT03982823 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Hand-Sewn Sleeve Gastrectomy
Description: After laparoscopic sleeve gastrectomy, gastrectomy site is hand-sewn with 3/0 polypropylene suture and the specimen is removed transorally.
Study NCT03982823 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Stapled Sleeve Gastrectomy
Description: Laparoscopic sleeve gastrectomy is performed via 60 mm linear stapler (Endo GIATM Ultra, Covidien) .
Study NCT02560233 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Contingent RT-fMRI-NF
Description: Subjects are provided with contingent RT-fMRI-NF of brain activity in the target region of interest.
Study NCT02560233 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Sham RT-fMRI-NF
Description: Subjects are provided with sham RT-fMRI-NF of brain activity of previously recorded subject.
Study NCT03006458 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: comfilcon A
Description: toric contact lens
Study NCT02592785 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BAY1163877
Description: Cohort 1: Single dose 600 mg on day 1, no drug on day 2 and then twice daily administration of the same dose for the remaining 19 days of cycle 1. From cycle 2 onwards all subjects are continuously treated for 21 days per cycle with twice daily administration of the same dose.~Cohort 2: Single dose 800 mg on day 1, no drug on day 2 and then twice daily administration of the same dose for the remaining 19 days of cycle 1. From cycle 2 onwards all subjects are continuously treated for 21 days per cycle with twice daily administration of the same dose.
Study NCT02526472 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ET under transabdominal US guidance (UGET)
Description: When UGET was used, a second physician performed trans-abdominal US, and the embryos were discharged when the tip of the catheter was visualized approximately at 1,5 cm from the fundal endometrial surface
Study NCT02526472 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: ET after transvaginal US uterine measurement (mTVET)
Description: When mTVET was scheduled, the physician performed a transvaginal US scan just before ET, measured the length of the cervix and of the uterine cavity, and calculated the distance between the internal uterine os and the fundal endometrial surface. Then, ET was performed inserting the inner cannula in order to discharge embryos at a point obtained subtracting 1.5 cm from the total length of the cavity.
Study NCT01863212 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Blood sampling for genetic analyse
Description: Blood sampling are performed at the initiation visit in order to screen for allele variants
Study NCT01863212 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Stroop test
Description: Selective attention test where subjects, in one minute, names the ink color of several words without naming the word itself.
Study NCT01863212 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: fMRI
Description: Functional Magnetic Resonance Imaging, performed to view brain activity
Study NCT02504008 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: AXS-02 (oral zoledronate)
Description: Once weekly for 6 weeks
Study NCT02504008 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Once weekly for 6 weeks
Study NCT03701347 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Reeve's model
Description: Reeves, K. O., Young, A. E., \& Kaufman, R. H. (1999). A simple, inexpensive device for teaching the loop electrosurgical excision procedure. Obstetrics and Gynecology, 94(3), 474-5.
Study NCT03701347 — intervention group
Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Hefler's model
Description: Hefler, L., Grimm, C., Kueronya, V., Tempfer, C., Reinthaller, A., \& Polterauer, S. (2012). A novel training model for the loop electrosurgical excision procedure: An innovative replica helped workshop participants improve their LEEP. American Journal of Obstetrics and Gynecology, 206(6)
Study NCT03701347 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Ida's model
Description: Reusable, portable and modular 3D printed simulator
Study NCT03176056 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Low carbohydrate diet
Description: For the LCD group, the daily carbohydrate intake was limited to less than 90g, without any restriction to total energy. The concept of a LCD was introduced and an educational 15 g equivalent carbohydrate food list was provided. The easy conversion method is that 15 g equivalent carbohydrate =1/4 bowel of rice= 1/2 bowel of noodle = 1 slice of toast = 3 soup-spoon of oats = one bowl of fruit =1/2 regular size banana= one glass of milk = 3 dumplings. Less than two equivalent 15g-carbohydrate intakes per meal were advised.